H-PRO-ALA-LEU-PRO-GLU-ASP-GLY-GLY-SER-GLY-ALA-PHE-PRO-PRO-GLY-HIS-PHE-LYS-ASP-PRO-LYS-ARG-LEU-TYR-OH
Modify Date: 2025-08-24 21:23:42
H-PRO-ALA-LEU-PRO-GLU-ASP-GLY-GLY-SER-GLY-ALA-PHE-PRO-PRO-GLY-HIS-PHE-LYS-ASP-PRO-LYS-ARG-LEU-TYR-OH structure
|
Common Name | H-PRO-ALA-LEU-PRO-GLU-ASP-GLY-GLY-SER-GLY-ALA-PHE-PRO-PRO-GLY-HIS-PHE-LYS-ASP-PRO-LYS-ARG-LEU-TYR-OH | ||
|---|---|---|---|---|
| CAS Number | 211362-85-5 | Molecular Weight | 2553.824 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C118H173N31O33 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of H-PRO-ALA-LEU-PRO-GLU-ASP-GLY-GLY-SER-GLY-ALA-PHE-PRO-PRO-GLY-HIS-PHE-LYS-ASP-PRO-LYS-ARG-LEU-TYR-OHBrain Derived Basic Fibroblast Growth Factor (1-24) (FGF basic 1-24) is a synthetic peptide, shows anti-bacterial and anti-HBV activities. Brain Derived Basic Fibroblast Growth Factor (1-24) can be used in infection disease and immune disease research[1]. |
| Name | L-Prolyl-L-alanyl-L-leucyl-L-prolyl-L-α-glutamyl-L-α-aspartylglycylglycyl-L-serylglycyl-L-alanyl-L-phenylalanyl-L-prolyl-L-prolylglycyl-L-histidyl-L-phenylalanyl-L-lysyl-L-α-aspartyl-L-prolyl-L-lysyl-L-arginyl-L-leucyl-L-tyrosine |
|---|---|
| Synonym | More Synonyms |
| Description | Brain Derived Basic Fibroblast Growth Factor (1-24) (FGF basic 1-24) is a synthetic peptide, shows anti-bacterial and anti-HBV activities. Brain Derived Basic Fibroblast Growth Factor (1-24) can be used in infection disease and immune disease research[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Brain Derived Basic Fibroblast Growth Factor (1-24) (10 μg/mL; 12 h) inhibits the growth of Streptococcus pneumoniae[1]. Brain Derived Basic Fibroblast Growth Factor (1-24) (10 μg/mL; 6 d) inhibits HBV replication of HepG2-2.2.15 cells[1]. Brain Derived Basic Fibroblast Growth Factor (1-24) (10 μg/mL; 22 h) inhibits the migration of human endothelial cell[1]. Cell Viability Assay[1] Cell Line: Streptococcus pneumoniae Concentration: 10 μg/mL Incubation Time: 12 hours Result: Inhibited by 100% the growth of Streptococcus pneumoniae. RT-PCR[1] Cell Line: HepG2-2.2.15 cells Concentration: 10 μg/mL Incubation Time: 6 days Result: Inhibited by 31.4% HBV replication as compared to the virus control infection. Cell Migration Assay [1] Cell Line: Human endothelial cells (HUVEC) Concentration: 10 μg/mL Incubation Time: 22 hours Result: Inhibited by 17% the migration of human endothelial cells |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Molecular Formula | C118H173N31O33 |
| Molecular Weight | 2553.824 |
| Exact Mass | 2552.281250 |
| LogP | -0.13 |
| Index of Refraction | 1.682 |
| L-Prolyl-L-alanyl-L-leucyl-L-prolyl-L-α-glutamyl-L-α-aspartylglycylglycyl-L-serylglycyl-L-alanyl-L-phenylalanyl-L-prolyl-L-prolylglycyl-L-histidyl-L-phenylalanyl-L-lysyl-L-α-aspartyl-L-pro
 lyl-L-lysyl-L-arginyl-L-leucyl-L-tyrosine |
| L-Tyrosine, L-prolyl-L-alanyl-L-leucyl-L-prolyl-L-α-glutamyl-L-α-aspartylglycylglycyl-L-serylglycyl-L-alanyl-L-phenylalanyl-L-prolyl-L-prolylglycyl-L-histidyl-L-phenylalanyl-L-lysyl-L-α-as
 partyl-L-prolyl-L-lysyl-L-arginyl-L-leucyl- |